2018.02

The following document contains CLASSYS’s proprietary information and is not intended to be used in any other manner other than expressly written.

All business and financial data contained herein are in compliance with Korean IFRS>

Any forecast within is not individually confirmed.

These are forward-looking statements that relate to the Company’s estimated business and financial performance, with expressions using ‘forecast’,

‘assessment’, ‘plan’, or ‘expectation’(‘E’).

Forward-looking information and/or any interpretation may be affected by business environments and thus includes inherent differences that may

vary from the final results.

In addition, all forward-looking information is based on current market condition and the Company’s present direction, and is subject to changes

without further notice, according to changes in the business environment or realignment of strategy.

The Company, its affiliates, advisors or representatives shall not be held responsible for any damages from use of information herein, including gross

negligence or otherwise.

This material cannot be used as evidence for responsibilities relating to the result of investment performance of the investor.

Disclaimer

All rights reserved

Company Overview Financial Status Competitiveness Growth Strategy Appendix

1) Information 1) Annual earnings 1) Development 1) Main Products 1) Consolidated F/S

2) Business Portfolio 2) Sales by Brand 2) Product Line-up 2) New Products 2) Separate F/S

① CLASSYS 3) Export Data 3) B2B Marketing 3) Cosmetic Business

② CLUEDERM 4) B2C Marketing 4) VISION

③ SKEDERM 5) Global Network

Contents

1) Information

2) Business Portfolio

① CLASSYS

② CLUEDERM

③ SKEDERM

Chapter 1. Company Overview

53%

35%

0.7% 0.03%2.4%

8%CEO

Related Party

AfreecaTV

KTB

CB

Etc.

Company Classy Inc.

CEO Sungjae Jung(Dr.)

Issue Date 10 Jan 2007

Listing Date 28 Dec 2017

Capital ₩ 6,047 million

HeadquarterClassys Tower, 240

Teheran –ro, Gangnam-gu, Seoul, Korea

Employees 129

Business* Medical Aesthetic Devices

* Cosmetic

Brands Classys, Cluederm, Skederm

SubsidiariesSkederm, Inc.(U.S.A)

Skederm Shanghai co., Ltd.(China)

Website http://www.classys.com

Contact 1544-3481

1. Information

Basic Information S/H

After CB convertedTotal Stocks61,973,077

Our name originates from “CLASSIC” and “SYSTEM”,

We create cutting-edge technologies to set new standards within our industry.

Lock-up

AfreecaTV 476,000 6 months

KTB SECURITIES 24,000 12 months

Total 500,000

CB Lock-up (Converting Period: ~2020.01.21)

AfreecaTV 24,000 6 months

RHINOS ASSET MANAGEMENT 400,000 6 months

Saint International 100,000 6 months

KTB SECURITIES 976,000 12 months

Total 1,500,000

Note: S/O 2,803,625. P=1,819, Period=19.08.30~26.08.29

5

2. Business Portfolio

The 3 Brands for each Distribution Network

CLASSYS

Medical

Cluederm

Aesthetic

SKEDERM

Cosmetic

6

HIFU Cooling energyHIFU

3. CLASSYS

High value Medical Devices Targeted at Hospitals

CLATUUUltraformer III(Shurink) Scizer

+ + +

Lifts and tightens the face for

a youthful complexion and

tightens the body for slimmer contours

Freeze stubborn fat in multiple areas

of the body to induce apoptosis

and achieve slimmer contours

Reduce stubborn fat cells

for customized and effective

body contouring

6.0mm 9.0mm

4.5mm

2.0mm

3.0mm

1.5mm

7

13.0mm

구분 식약처허가사용목적

울트라포머III(국내명 슈링크)

고강도집속형초음파수술기로조직을 응고하여 눈썹리프팅(카트리지모델: L4-4.5, L7-1.5, L2-3. OW, L7-1.5W,MF5, MF2)에 이용하며 얼굴(양볼)(카트리지모델: MF1, MF3, MF4), 복부 및 허벅지(카트리지모델: MF1, MF3, MF6, MF9)피부와피하조직의 탄력개선에 사용하는 기구입니다.

사이저 BMI 지수 30kg/m2 이하이고, 복부지방 두께가 2.5cm 이상인 사람의 경우 복부둘레 평균 2cm 내외의 감소에 도움을 주는 기기입니다.

클라투 환부를 낮은 온도로 유지하여 통증의 완화, 부종의 경감, 비침습적 피하 지방층 감소 등에 사용되는 기구입니다.

Ulfit

Aquapure

4. Cluederm

Special Brand targeted at Global Aesthetic Shops

Cool4D

Refit

+

+ +

HIFU

Lifts and tightens the face for

a youthful complexion and

tightens the body for slimmer contours

Cooling energy

Freeze stubborn fat in multiple areas

of the body to induce apoptosis

and achieve slimmer contours

Vacuum

Facial Care System

(Skin Rejuvenation, Exfoliation & Extraction,

Deep Pore Cleansing, Skin Elasticity)

RF

+

Vacuum

Skin Rejuvenation & Tightening

Blood Circulation & Lymphatic Drainage

9mm6mm

8

+

구분 식약처허가사용목적

울핏집속형초음파자극시스템으로조직을 응고하여눈썹리프팅(카트리지모델 : F7-1.5, F7-3.0, F4-4.5)에이용하며, 얼굴(양볼) (카트리지 모델 : LMF1, LMF3, LMF4), 복부 및 허벅지(카트리지모델 : B2-3.0, B2-6.0, B2-9.0)의피부와 피하조직의 탄력개선에 사용

리핏 780kHz의 고주파 에너지를 가하여 인체에 심부열에 발생시켜 통증완화에 사용하는 기구입니다.

쿨포디 환부를 낮은 온도로 유지하여 통증의 완화, 부종의 경감, 비침습적 피하 지방층 감소 등에 사용되는 기구입니다.

5. SKEDERM

Total Skin Care Brand targeted at the Cosmetic and Beauty Device market

Eye CreamNeck CreamCleanserLifting Patch Cushion Cover Cushion

∙∙∙ ∙∙∙Night CreamSerum Gel cream

Visit www.skederm.com / www.amazon.com

9

1. Annual Earnings

2. Sales by Brand

3. Export Data

Chapter 2. Financial Status

10years

60countries

SALESPROFIT

1. Financial Status

Sales OP

25

45

71

19.3%

29.7%

26.0%

0.0 %

5.0 %

10. 0%

15. 0%

20. 0%

25. 0%

30. 0%

35. 0%

40. 0%

-

20

40

60

80

100

120

140

160

180

200

2014 2015 2016 2017

NI NIM

NI

[unit: 100 ₩ million] [unit: 100 ₩ million] [unit: 100 ₩ million]

11

131

150

272

349

2014 2015 2016 2017

26

40

82

109

20.2%

26.5%

30.1%31.4%

0.0 %

5.0 %

10. 0%

15. 0%

20. 0%

25. 0%

30. 0%

35. 0%

40. 0%

-

20

40

60

80

100

120

140

160

180

200

2014 2015 2016 2017

OP OPM

109 112

179

32

36

2

1936

55

2014 2015 2016 2017

Expendable Items

Skederm

Cluederm

Classys

[unit: 100 ₩ million]

2. Sales by Brand

131

150

272

12

0.7%

83%

15%

66%

20%

13%

75%

24%

Classys Cluederm Skederm Expendable Items

76 68 84

55 82

188

2014 2015 2016 2017

3. Export Data

[unit: 100 ₩ million]

131

150

272

0

13

Export Domestic

42%58%

69%

31%

55%45%

1. Development

2. Product Line-up

3. B2B Marketing

4. B2C Marketing

5. Global Network

Chapter 3. Competitiveness

Developing Well-made Products desired in the Market

1. Development

CS TrainingProduce

Develop

Licensing

AgencyHospital

(Doctor)

Trust from our customers is our most important asset.

We only make products that can strengthen our relationship with customers.

Self Design Self Assembly Self Certify Self Educate Self Manage

Feedback

Feedback

Feedback

Feedback

15

★

2. Product Line-up

Building our portfolio by making new devices and continuously upgrading

Vacuum

Cooling Energy

HIFU

LASER

RF • Vectorcube

• Epilogue

• Allegro • Allegro II

• Ultraformer

• CLATUU

• Ultraformer III

(Shurink)

• Cool4D

• Scizer

• Refit

• Ulfit

• Cryolipo

• SKEDERM

↑ Tech.

Year →

• Medical

New Business

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 ~

• Aquapure

• Touchwave

• TONUP

• TAIET

• Airpunch

16

• Aesthetic • Cosmetic

3. B2B Marketing

Marketing based on key doctor testimonials from the meticulous medical device industry

Opinion Leaders Symposium

17

Exhibition / Conference / Academy/ Symposium etc.

Social Media / Media / Magazine

4. B2C Marketing

PR to the general public to expand the base of consumers and increase sales of expendable items

Facebook Followers 1: Skederm 205,835 Classys HQ 196,169

FacebookClassyspage

FacebookSkedermpage

Media

Magazines

Inform the public

Procedures become popular

Sales of expendable items increase

Note. 2017.10.17

18

5. Global Network

Exporting to more than 60 countries and continuously expanding our network

Skederm, Inc.

Skederm Shanghai co., Ltd.

Domestic Direct

Domestic Agency

Europe- Greece- Germany- Romania- Bulgaria- Sweden- Switzerland- Spain- Slovenia- Estonia, - Italy- Czech Republic- Poland- France, - Finland- Hungary- Netherland- Norway- Denmark- UKetc

Middle East- Iraq - Iran - Israel - Turkey- UAE- Lebanonetc

Asia- Malaysia- Vietnam- Singapore- India- Indonesia- Japan- China- Thailand- Bangladesh- Philippine- Hong Kongetc

Australia- Australia

- New Zealand

South America- Brazil- Argentina- Chile- Colombia- Peruetc

Africa- Kenyaetc

• Sale Cosmetic• Manage

customs clearance and agency• Medical devices will be added

19

• Sale Cosmetic• Manage

customs clearance and agency• Medical devices will be added

.

Present Future

1. Main Products

2. New Products

3. Cosmetic Business

4. VISION

Chapter 4. Growth Strategy

Cosmetic

Strategies for sustained growth with existing products such as the Ultraformer III

1. Main Products

2014 permitted to lift eyebrows by KFDA

2016 permitted to lift and tighten

the face and body by KFDA

2016 Registered in 10 different countries

2017 Registered in Brazil

Add Global Registration

Increase additional global agencies

Accumulate Clinical Cases

and Promote Marketing

Upgrade Products and Expendable Items

21

Ultraformer III

(Shurink)Strategy

TAIET Touchwave TONUP Laser Air Punch

Increase the M/S by developing New Products

2. New Products

VacuumLaser Laser Galvanic Ion Booster

TouchWave

22

3. Cosmetic Business

Expanding the distribution network at home and abroad

23

Company

Website

Online

Mall

Off-line

shop

Duty Free

Shop

U.S.A China Europe Thailand OthersHong Kong

www.skederm.com

www.skederm.co.kr

Amazon

G-market/ Auction/ Interpark

11 st/ Lotte.com/ AKmall

Lotte/ NS Homeshopping

AK Plaza

LOHB’s

Angel Beauty Bar

(HK H&B Store)

On-line mall: Lotte Duty Free

Off-line shop

inflight

(in talk)

Get certified and licensed in each country

4. Vision

우리는연구합니다.

We are continuously

researching.

24

Sustainable Growth

1. Consolidated F/S

2. Separate F/S

Appendix

- 2014 2015 2016 1H17

Current Assets 6,706 10,024 18,400 20,742

Non-current Assets 888 2,458 3,640 7,133

Total Assets 7,594 12,482 22,040 27,875

Current Liabilities 1,997 3,131 5,519 6,341

Non-currentLiabilities

138 103 193 193

Total Liabilities 2,135 3,234 5,712 6,534

Capital Stock 100 100 100 100

Other Reserves 0 0 8 44

Retained Earnings 5,359 9,148 16,220 21,197

Shareholder’s Equity 5,459 9,248 16,328 21,341

- 2014 2015 2016 1H17

Sales 13,058 14,996 27,243 18,338

COGS 4,346 3,705 8,649 6,012

GP 8,711 11,290 18,594 12,325

SG&A 6,072 7,314 10,329 6,124

OP 2,638 3,977 8,265 6,201

Other Income 210 510 492 202

Other Expenses 49 19 28 3

Financial Income 419 1,041 567 83

Financial Expenses 73 59 523 285

Pre-tax Income 3,144 5,449 8,773 6,197

Tax 629 759 1,701 1,220

NI 2,515 4,689 7,072 4,977

I/S [unit: ₩ million] B/S [unit: ₩ million]

26

1. Consolidated F/S

- 2014 2015 2016 1H17

Current Assets 6,706 10,024 18,400 20,571

Non-current Assets 790 2,132 3,640 7,341

Total Assets 7,496 12,155 22,040 27,913

Current Liabilities 1,997 3,131 5,519 6,320

Non-currentLiabilities

138 103 193 193

Total Liabilities 2,135 3,234 5,712 6,513

Capital Stock 100 100 100 100

Other Reserves 0 0 8 55

Retained Earnings 5,261 8,821 16,220 21,245

Shareholder’s Equity 5,361 8,921 16,328 21,400

- 2014 2015 2016 1H17

Sales 13,058 14,996 27,243 18,184

COGS 4,346 3,705 8,649 6,009

GP 8,711 11,290 18,594 12,174

SG&A 6,072 7,314 10,329 5,925

OP 2,638 3,975 8,265 6,249

Other Income 210 510 492 202

Other Expenses 49 19 28 3

Financial Income 419 1,041 567 84

Financial Expenses 73 59 523 285

Pre-tax Income 3,144 5,449 8,773 6,245

Tax 629 759 1,701 1,220

NI 2,515 4,460 7,072 5,025

I/S [unit: ₩ million] B/S [unit: ₩ million]

27

2. Separate F/S

IR Team Yugene Choi+82-70-5168-8000

ir@classys.comClassys Tower, 240, Teheran-ro, Gangnam-gu, Seoul, Korea